These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 15274302

  • 21. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL, Madden T, Andreeff M.
    Cancer Res; 2003 Sep 15; 63(18):5926-39. PubMed ID: 14522919
    [Abstract] [Full Text] [Related]

  • 22. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 23. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan 01; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug 01; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 25. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct 01; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 26. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y, Ito I, Wayama M, Fujimura A, Akaogi K, Machida H, Nakajima Y, Kuroda T, Ohmori K, Murayama A, Kimura K, Yanagisawa J.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):145-8. PubMed ID: 18355447
    [Abstract] [Full Text] [Related]

  • 27. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D, Yoshihiro H, Nakanishi M, Naruyama H, Okada S, Ando R, Tozawa K, Kohri K.
    Cancer Detect Prev; 2008 May 23; 32(3):259-66. PubMed ID: 18789607
    [Abstract] [Full Text] [Related]

  • 28. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
    Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, Chuang SE.
    Mol Carcinog; 2010 Mar 23; 49(3):235-46. PubMed ID: 19908241
    [Abstract] [Full Text] [Related]

  • 29. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
    Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H.
    Gastroenterology; 2003 Feb 23; 124(2):361-7. PubMed ID: 12557142
    [Abstract] [Full Text] [Related]

  • 30. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M, Lee TW, Yim AP, Mok TS, Chen GG.
    J Cell Physiol; 2006 Nov 23; 209(2):428-38. PubMed ID: 16883598
    [Abstract] [Full Text] [Related]

  • 31. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
    Kim HJ, Woo IS, Kang ES, Eun SY, Kim GH, Ham SA, Kim HJ, Lee JH, Chang KC, Kim JH, Lee HT, Seo HG.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):660-7. PubMed ID: 16945329
    [Abstract] [Full Text] [Related]

  • 32. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T.
    J Clin Endocrinol Metab; 2001 May 20; 86(5):2170-7. PubMed ID: 11344222
    [Abstract] [Full Text] [Related]

  • 33. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.
    Rumi MA, Sato H, Ishihara S, Ortega C, Kadowaki Y, Kinoshita Y.
    J Lab Clin Med; 2002 Jul 20; 140(1):17-26. PubMed ID: 12080324
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma.
    Rumi MA, Sato H, Ishihara S, Kawashima K, Hamamoto S, Kazumori H, Okuyama T, Fukuda R, Nagasue N, Kinoshita Y.
    Br J Cancer; 2001 Jun 15; 84(12):1640-7. PubMed ID: 11401318
    [Abstract] [Full Text] [Related]

  • 35. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
    Yu HN, Noh EM, Lee YR, Roh SG, Song EK, Han MK, Lee YC, Shim IK, Lee SJ, Jung SH, Kim JS, Youn HJ.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):242-7. PubMed ID: 18835379
    [Abstract] [Full Text] [Related]

  • 36. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Zhu H, Pan X, Qi H, Wang X, Hou S, Han B, Liu Z, Xu L.
    Oncol Rep; 2011 Jan 05; 25(1):81-90. PubMed ID: 21109961
    [Abstract] [Full Text] [Related]

  • 37. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A, Faried LS, Kimura H, Sohda M, Nakajima M, Miyazaki T, Kato H, Kanuma T, Kuwano H.
    Cancer Chemother Pharmacol; 2006 Feb 05; 57(3):301-8. PubMed ID: 16028102
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.
    Motomura W, Nagamine M, Tanno S, Sawamukai M, Takahashi N, Kohgo Y, Okumura T.
    J Gastroenterol; 2004 Feb 05; 39(5):461-8. PubMed ID: 15175945
    [Abstract] [Full Text] [Related]

  • 39. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM, Waxman DJ.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):275-84. PubMed ID: 15364543
    [Abstract] [Full Text] [Related]

  • 40. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T.
    Int J Cancer; 2004 Jan 01; 108(1):41-6. PubMed ID: 14618613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.